# CUPRIC CHLORIDE
> **ANDA212071** · Abbreviated New Drug Application (Generic) · Sponsor: EXELA PHARMA · Approved 2022-10-31
## Drug
- **FDA Application Number:** ANDA212071
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CUPRIC CHLORIDE
- **Generic name:** CUPRIC CHLORIDE
- **Active ingredients:** CUPRIC CHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** EXELA PHARMA
- **Manufacturer:** Exela Pharma Sciences, LLC
- **First approval:** 2022-10-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212071)
---
*AI Analytics · CC0 1.0*